142 related articles for article (PubMed ID: 37023991)
41. Melittin inhibits lung metastasis of human osteosarcoma: Evidence of wnt/β-catenin signaling pathway participation.
Zhu H; Chen D; Xie X; Li Y; Fan T
Toxicon; 2021 Jul; 198():132-142. PubMed ID: 33930393
[TBL] [Abstract][Full Text] [Related]
42. Wnt signaling in osteosarcoma.
Lin CH; Ji T; Chen CF; Hoang BH
Adv Exp Med Biol; 2014; 804():33-45. PubMed ID: 24924167
[TBL] [Abstract][Full Text] [Related]
43. Inactive Wnt/beta-catenin pathway in conventional high-grade osteosarcoma.
Cai Y; Mohseny AB; Karperien M; Hogendoorn PC; Zhou G; Cleton-Jansen AM
J Pathol; 2010 Jan; 220(1):24-33. PubMed ID: 19882675
[TBL] [Abstract][Full Text] [Related]
44. LINC01128 regulates the development of osteosarcoma by sponging miR-299-3p to mediate MMP2 expression and activating Wnt/β-catenin signalling pathway.
Yao Q; Chen T
J Cell Mol Med; 2020 Dec; 24(24):14293-14305. PubMed ID: 33108067
[TBL] [Abstract][Full Text] [Related]
45. Histone methyltransferase SETD2 regulates osteosarcoma cell growth and chemosensitivity by suppressing Wnt/β-catenin signaling.
Jiang C; He C; Wu Z; Li F; Xiao J
Biochem Biophys Res Commun; 2018 Jul; 502(3):382-388. PubMed ID: 29842882
[TBL] [Abstract][Full Text] [Related]
46. Long noncoding RNA KCNQ1OT1 contributes to tumor growth and activates Wnt/β‑catenin signaling in osteosarcoma by targeting the miR‑3666/KLF7 axis.
Huang A; Jin S; Han W; Wang Y; Ma S; Wang Z; Lin K; Zou Q; Zhou J; Li Z; Chen L
Int J Mol Med; 2021 Jan; 47(1):387-396. PubMed ID: 33416089
[TBL] [Abstract][Full Text] [Related]
47. Tegavivint and the β-Catenin/ALDH Axis in Chemotherapy-Resistant and Metastatic Osteosarcoma.
Nomura M; Rainusso N; Lee YC; Dawson B; Coarfa C; Han R; Larson JL; Shuck R; Kurenbekova L; Yustein JT
J Natl Cancer Inst; 2019 Nov; 111(11):1216-1227. PubMed ID: 30793158
[TBL] [Abstract][Full Text] [Related]
48. Rapamycin-induced autophagy in osteosarcoma cells is mediated via the biglycan/Wnt/β-catenin signaling axis.
Giatagana EM; Berdiaki A; Gaardløs M; Tsatsakis AM; Samsonov SA; Nikitovic D
Am J Physiol Cell Physiol; 2022 Dec; 323(6):C1740-C1756. PubMed ID: 36280393
[TBL] [Abstract][Full Text] [Related]
49. IWR-1, a tankyrase inhibitor, attenuates Wnt/β-catenin signaling in cancer stem-like cells and inhibits in vivo the growth of a subcutaneous human osteosarcoma xenograft.
Martins-Neves SR; Paiva-Oliveira DI; Fontes-Ribeiro C; Bovée JVMG; Cleton-Jansen AM; Gomes CMF
Cancer Lett; 2018 Feb; 414():1-15. PubMed ID: 29126913
[TBL] [Abstract][Full Text] [Related]
50. Nasopharyngeal carcinoma‑associated gene 6 inhibits cell viability, migration, invasion and induces apoptosis in osteosarcoma cells by inactivating the Wnt/β‑catenin signaling pathway.
Liu L; Wang R; Zhang Z; Wang X
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33300077
[TBL] [Abstract][Full Text] [Related]
51. MicroRNA-340-5p suppresses osteosarcoma development by down-regulating the Wnt/β-catenin signaling pathway via targeting the STAT3 gene.
Rongxin S; Pengfei L; Li S; Xiaochen J; Yihe H
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):982-991. PubMed ID: 30779064
[TBL] [Abstract][Full Text] [Related]
52. Thiram, an inhibitor of 11ß-hydroxysteroid dehydrogenase type 2, enhances the inhibitory effects of hydrocortisone in the treatment of osteosarcoma through Wnt/β-catenin pathway.
Zhang Y; Li N; Li H; Chen M; Jiang W; Guo W
BMC Pharmacol Toxicol; 2023 Mar; 24(1):20. PubMed ID: 36978114
[TBL] [Abstract][Full Text] [Related]
53. LncRNA BE503655 inhibits osteosarcoma cell proliferation, invasion/migration via Wnt/β-catenin pathway.
Huang Q; Shi SY; Ji HB; Xing SX
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31316000
[No Abstract] [Full Text] [Related]
54. Carvacrol Suppresses Human Osteosarcoma Cells via the Wnt/β-Catenin Signaling Pathway.
Zhang S; He L; Shang J; Chen L; Xu Y; Chen X; Li X; Jiao Q; Jin S; Hu X; Liang W
Anticancer Agents Med Chem; 2022; 22(9):1714-1722. PubMed ID: 34488595
[TBL] [Abstract][Full Text] [Related]
55. miR-425-5p decreases LncRNA MALAT1 and TUG1 expressions and suppresses tumorigenesis in osteosarcoma via Wnt/β-catenin signaling pathway.
Yang G; Zhang C; Wang N; Chen J
Int J Biochem Cell Biol; 2019 Jun; 111():42-51. PubMed ID: 30986552
[TBL] [Abstract][Full Text] [Related]
56. ALOX5AP suppresses osteosarcoma progression via Wnt/β-catenin/EMT pathway and associates with clinical prognosis and immune infiltration.
Han GD; Dai J; Hui HX; Zhu J
J Orthop Surg Res; 2023 Jun; 18(1):446. PubMed ID: 37344882
[TBL] [Abstract][Full Text] [Related]
57. Up-regulation of microRNA-340 promotes osteosarcoma cell apoptosis while suppressing proliferation, migration, and invasion by inactivating the CTNNB1-mediated Notch signaling pathway.
Pan BL; Wu L; Pan L; Yang YX; Li HH; Dai YJ; He ZQ; Tan L; Huang YG; Tong ZW; Liao JL
Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29769415
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of the Wnt-β-catenin and Notch signaling pathways sensitizes osteosarcoma cells to chemotherapy.
Ma Y; Ren Y; Han EQ; Li H; Chen D; Jacobs JJ; Gitelis S; O'Keefe RJ; Konttinen YT; Yin G; Li TF
Biochem Biophys Res Commun; 2013 Feb; 431(2):274-9. PubMed ID: 23291185
[TBL] [Abstract][Full Text] [Related]
59. Baicalein mediates the anti-tumor activity in Osteosarcoma through lncRNA-NEF driven Wnt/β-catenin signaling regulatory axis.
Zhang FW; Peng LY; Shi CJ; Li JC; Pang FX; Fu WM; Pan XH; Zhang JF
J Orthop Translat; 2022 Mar; 33():132-141. PubMed ID: 35330943
[TBL] [Abstract][Full Text] [Related]
60. Ginsenoside impedes proliferation and induces apoptosis of human osteosarcoma cells by down-regulating β-catenin.
Li XF; Zhao GQ; Li LY
Cancer Biomark; 2019; 24(4):395-404. PubMed ID: 30909183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
